# Bioequivalence of Two Tablet Forms of MK0974 (0974-045)

> **NCT00965887** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 36 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** MK0974 Ethanolate formulation
- **DRUG:** Comparator: MK0974 Hydrate formulation

## Key facts

- **NCT ID:** NCT00965887
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965887, "Bioequivalence of Two Tablet Forms of MK0974 (0974-045)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00965887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*